Endocannabinoids (eCBs) are endogenous lipid mediators that activate the cannabinoid-1
and-2 receptors (CB 1 R and CB 2 R, respectively), which mediate the effects of marijuana …

The endocannabinoid system (ECS) comprises cannabinoid receptors (CB1R and CB2R),
endogenous lipid ligands (endocannabinoids) and enzymes that synthesize and degrade …

Endocannabinoids (ECs) regulate energy balance by modulating hypothalamic circuits
controlling food intake and energy expenditure. However, convincing evidence has …

Metabolic syndrome is a complex disease state, which appears mostly as a consequence of
an unhealthy, sedentary lifestyle. Metabolic complications include insulin resistance (IR) …

Scientific interest in the endocannabinoid (EC) system developed as a result of the known
effects of tetrahydrocannabinol, including an increased desire to consume food. Further …

The endocannabinoid (EC) signaling (ECS) system involves the activation of receptors
targeted by endogenously produced ligands called endocannabinoids that trigger specific …

Endocannabinoids are endogenous lipid mediators that interact with the same receptors as
plant-derived cannabinoids to produce similar biological effects. The well-known appetitive …

The endocannabinoid system (ECS) favors the intake and storage of energy by acting
through both central and peripheral mechanisms. In particular, the ECS is present in the …

Endocannabinoids (ECBs) are ubiquitous lipid mediators that act through the same G
protein-coupled receptors (CB 1 and CB 2) that recognize plant-derived cannabinoids. As …

The endocannabinoid system (ECS) is composed of lipid signalling ligands, their G-protein
coupled receptors and the enzymes involved in ligand generation and metabolism …